Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Research Article Volume 3 Issue 9

Maternal and Fetal Outcome in Corona Positive Pregnant Women

Anita Kant1*, Amrita Razdan Kaul2 and Komal3

1Chairman, Department of Obstetrics and Gynecology, Asian Institute of Medical Sciences, Faridabad, Haryana, India
2Consultant, Department of Obstetrics and Gynecology, Asian Institute of Medical Sciences, Faridabad, Haryana, India
3Department of Obstetrics and Gynecology, Asian Institute of Medical Sciences, Faridabad, Haryana, India

*Corresponding Author: Anita Kant, Chairman, Department of Obstetrics and Gynecology, Asian Institute of Medical Sciences, Faridabad, Haryana, India.

Received: August 13, 2021; Published: August 31, 2021


Background: COVID-19 has shown accelerated rate of spread globally with viral pneumonia as one of the leading causes of pregnancy deaths. Compromised immune status with physiological respiratory alterations predispose pregnant population to worsened outcome with COVID-19 infection.

Aim: Aim of this prospective case study is to evaluate impact of COVID-19 outbreak on maternal and fetal outcome in COVID positive pregnant women.

Material and Methods: This systematic review is a prospective study of maternal and fetal outcome in 60 corona positive pregnant women admitted at AIMS Faridabad in a period of 15 months (March 2020-May 2021). Positive patients were divided into asymptomatic and symptomatic group.

Observation: The study population comprised of 4 women from 20-25 years, 22 women from 26-30 years and 34 women from above 30 years. 30 were primigravida and 30 multi. 21 were asymptomatic, 39 were symptomatic. Out of 39 females, 12 were having mild disease, 16 moderate and 11 had severe to critical disease. Out of 60 cases, 16 continued with pregnancy, 41 cases delivered and 3 had early abortions. There were 3 IUDs and 4 maternal mortalities. LSCS was the common mode of delivery.

Conclusions: In wake of second wave of this epidemic, our study attempts to unravel meaningful factors to deal with symptoms and phenomenon specific to pregnant COVID-19 positive pregnant women to lessen the burden and severity of the disease in this vulnerable population.

Keywords: COVID-19; Pregnant Women; SARS-CoV-2


  1. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395 (2020): 497-506.
  2. Abuelgasim E., et al. “COVID-19: Unique public health issues facing black, Asian and minority ethnic communities”. Current Problems in Cardiology 8 (2020): 100621.
  3. Schwartz DA and Graham AL. “Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections”. Viruses 12 (2020): 1-16.
  4. Siston A M., et al. “Pandemic 2009 influenza A (HINI) virus illness among pregnant women in the United States”. JAMA 303 (2010): 1517-1525.
  5. Jamieson D J., et al. “Emerging infections and pregnancy”. Emerging Infectious Diseases 12 (2020): 1638-1643.
  6. José Villar., et al. “Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection”. JAMA Pediatrics (2021).
  7. Liu Y., et al. “Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy”. Journal of Infection (2020).
  8. Liu H., et al. “Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children”. Journal of Infection5 (2020): e713.
  9. FIGO statement, COVID-19 in pregnancy- march (2021).
  10. Shanes ED., et al. “Placental pathology in COVID-19”. American Journal of Clinical Pathology 1 (2020): 23-32.
  11. Elshafeey F., et al. “A systematic scoping review of COVID-19 during pregnancy and childbirth”. International Journal of Gynecology and Obstetrics 1 (2020): 47-52.
  12. D Mascio Di., et al. “Outcome of coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta-analysis”. American Journal of Obstetrics and Gynecology MFM (2020): 100107.
  13. Liang H and Acharya G. “Novel Corona Virus Disease (COVID-19) in pregnancy: What clinical recommendations to follow?” Acta Obstetricia et Gynecologica Scandinavica4 (2020): 43942.
  14. Favre G., et al. “Guidelines for pregnant women with suspected SARS-CoV-2 infection”. Lancet Infectious Disease (2020): S14733099 (20)30157-2.
  15. “Considerations for Inpatient Obstetric Healthcare Settings”.
  16. “Clinical management of severe acute respiratory infection when COVID-19 is suspected”.


Citation: Anita Kant., et al. “Maternal and Fetal Outcome in Corona Positive Pregnant Women”. Acta Scientific Women's Health 3.9 (2021): 48-52.


Copyright: © 2021 Anita Kant.,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US